2005
Möller S, Mix E, Blüggel M, Serrano-Fernández P, Koczan D, Kotsikoris V, Kunz M, Watson M, Pahnke J, Illges H, Kreutzer M, Mikkat S, Thiesen HJ, Glocker MO, Zettl UK,Ibrahim SM (2005):
Collection of soluble variants of membrane proteins for transcriptomics and proteomics.
In Silico Biol 5: 295-311
Pelaez I.M., Vogler S., Strauss U., Wernhoff P., Pahnke J., Brockmann G., Moch H., Thiesen H.J., Rolfs A., Ibrahim S.M. (2005):
Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: Correlation with incidence, onset and severity of disease.
Hum Mol Genet 14: 1977-1989
Rateitschak K, Lange C, Mix E, Rolfs A, Wolkenhauer O (2005):
Systembiologie des kanonischen Wnt-Signalweges.
Laborpraxis 29: 24-26
Rolfs A., Böttcher T., Zschiesche M., Morris P., Winchester B., Bauer P., Walter U., Mix E., Löhr M., Harzer K., Strauss U., Pahnke J., Grossmann A., Benecke R. (2005):
High prevalence of Fabry disease in young stroke patients.
Lancet 366: 1794-1796
Steiner M., Steiner B., Rolfs A., Wangnick M., Burstein C., Freund M., Schuff-Werner P. (2005):
Antithrombin gene mutation 5356-5364*delCTT with type I deficiency and early-onset thrombophilia and a brief review of the antithrombin alpha-helix D molecular pathology.
Ann Hematol. 84: 56-58 Erratum in: Ann Hematol. 2005 Jul;84(7):485-6.
Strauss U. Herbrik M., Mix E., Bajorat R., Jung S., Gimsa U., Rolfs A. (2005):
Dopamine exers no acute effects on Kv1.3 in activated encephalitogenic T cells.
Neuroimmunomodulaion 12: 45-53
Bajorat R.; Bräuner A.; Wasner U.; Rolfs A.; Strauss U. (2005):
Functional Significance of HCN2/3-Mediated Ihin Stratial Cells at Early Developmental Stages.
Journal of Neuroscience Research 82:206-213 (2005)